EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis

被引:0
作者
Shaofei Chen
Jiarui Pu
Jie Bai
Yuping Yin
Ke Wu
Jiliang Wang
Xiaoming Shuai
Jinbo Gao
Kaixiong Tao
Guobin Wang
Hang Li
机构
[1] Union Hospital,Department of Gastrointestinal Surgery
[2] Tongji Medical College,Department of Pediatric Surgery
[3] Huazhong University of Science and Technology,undefined
[4] Union Hospital,undefined
[5] Tongji Medical College,undefined
[6] Huazhong University of Science and Technology,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 37卷
关键词
Galectin-9; EZH2; Hepatocellular carcinoma; Proliferation; Metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 209 条
[1]  
Chen W(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132
[2]  
Zheng R(2003)Hepatocellular carcinoma Lancet 362 1907-1917
[3]  
Baade PD(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30
[4]  
Zhang S(2013)Galectin-9 in tumor biology: a jack of multiple trades Biochim Biophys Acta 1836 177-185
[5]  
Zeng H(2009)Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation Clin Immunol 132 184-194
[6]  
Bray F(2012)Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma Hepatology 56 1342-1351
[7]  
Llovet JM(2015)Galectin-9 is involved in immunosuppression mediated by human bone marrow-derived clonal mesenchymal stem cells Immune Netw 15 241-251
[8]  
Burroughs A(2003)Galectin-9 induces apoptosis through the calcium-Calpain-Caspase-1 pathway J Immunol 170 3631-3636
[9]  
Bruix J(2016)Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis Gut 65 1186-1201
[10]  
Siegel RL(2017)Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (review) Int J Oncol 50 345-355